A novel gene therapy enables a drug to dampen the activity of brain cells, reducing seizures in laboratory experiments.

What it means

A team reports a gene therapy that introduces a genetic switch into hyperactive brain cells, allowing a subsequently administered drug to selectively dampen their activity and quash seizures. The approach, described in a new study, offers a way to temporarily calm overactive neurons on demand rather than permanently altering their behavior.

Accuracy & sourcesGrounded

The claim is derived from a news article by Science (AAAS), a reputable secondary outlet, which appears to closely summarize a peer-reviewed study. The grounding confirms the article was published on November 6, 2026, lending recency and a clear connection to the primary research.

How new

Genuinely new — the article was published on November 6, 2026, and reports on contemporaneous research.

Go deeper

• Science (AAAS) News — first to publish